Point-of-Care Campaign Measurement: Pixels, Conversions, and Physician Engagement
How point of care campaign measurement works, what tracking pixels and conversion events can capture in EHR and clinical apps, and why there is no typical ROI.
The short answer
Point-of-care campaign measurement usually relies on the platform's own reporting rather than your tracking pixels, because many EHR, e-prescribing, and clinical reference environments restrict third-party tags. Where pixels are allowed, you set up conversion events on your HCP site for actions such as sample requests or resource downloads. The outcome that matters, prescription lift, is measured by linking exposed NPIs to Rx data through a measurement partner. There is no single typical ROI for point-of-care channels or for any one publisher such as Epocrates.
Point-of-care media covers a few different things that get lumped together: messages inside EHR and e-prescribing workflows, ads in clinical reference apps used by physicians, and screens in exam rooms and waiting rooms aimed at patients. They share a name and very little else. Measurement is different for each, and setting up tracking the way you would for open-web programmatic often fails quietly.
This article is part of the outcomes measurement platforms series. For the wider channel view, see NPI marketing beyond display.
Point-of-care channels and what each can track
| Channel | Audience | What is usually trackable | Third-party pixels |
|---|---|---|---|
| EHR workflow messages | HCPs during charting or ordering | Impressions and interactions by NPI, reported by platform | Often not allowed inside the workflow |
| E-prescribing messages | HCPs at the moment of prescribing | Message served, viewed, actioned (platform reported) | Often restricted |
| Clinical reference apps (drug reference, decision support) | HCPs looking up drugs or conditions | Impressions, clicks, content engagement, often by NPI for logged-in users | Varies by placement; some allow impression trackers |
| Exam room and waiting room screens | Patients and caregivers | Screens, plays, estimated audience; QR scans if used | Not applicable for screens; landing page tags work after a scan |
Rules change and differ by partner, so treat the pixel column as a starting assumption to confirm, not a fact about any specific publisher.
How to set up tracking pixels or conversion events for a point-of-care campaign
The setup has two halves: what happens inside the point-of-care placement, and what happens if the physician clicks out to your site.
- Ask each partner, in writing, what tags they accept. Impression trackers, click trackers, viewability tags, or none. Get the answer per placement, not per publisher.
- Use click trackers and UTM parameters on all outbound links. This is usually allowed even where impression pixels are not, and it lets you tie site visits back to the placement.
- Define conversion events on your HCP site. Sample request started and completed, savings program enrollment, prescribing information view, resource download, rep contact request. Keep the list short.
- Tag those events through your tag manager under the brand's pixel governance rules. HCP sites are usually less sensitive than patient sites, but the same review discipline applies. See tracking pixel governance on pharma and health websites.
- Validate before launch. Fire every event in a test environment and confirm it lands in reporting. The tag validation guide has a checklist.
- Request NPI-level engagement files. Many POC platforms can provide engagement by NPI. That file is what makes an Rx lift study possible later.
What usually goes wrong: a pixel is trafficked into a placement that silently strips it, the report shows zero impressions from that partner, and nobody notices for three weeks. Check partner-reported numbers against your ad server on day two.
Measuring physician engagement without overreading it
Engagement inside clinical workflow is different from engagement on a news site. A physician dismissing an e-prescribing message in two seconds is normal behavior, not a failed ad. A click is rare and may mean the physician wanted more information or tapped by accident.
Useful engagement signals for POC are reach against your NPI target list, frequency by NPI, and specific actions like a coverage lookup or sample request. CTR alone is a weak guide. The HCP engagement metrics guide covers what each signal can support.
A second caution: engagement is almost always reported by the publisher. That does not make it wrong, but it does mean you should ask how an impression or a view is defined and whether any part of the reporting is independently audited, for example against MRC standards.
Rx lift studies for point-of-care campaigns
Most POC publishers support prescription lift studies, either through their own analytics or through measurement partners. The mechanics match other HCP studies: exposed NPIs are matched to prescription data and compared with a control group. The process is described in how to attribute prescription lift to programmatic HCP media.
Two POC-specific issues come up often.
- Timing bias. EHR and e-prescribing messages fire when a physician is already treating a relevant patient. Those physicians were more likely to write in the class anyway. A good control accounts for this, for example by comparing against physicians who triggered the same clinical moment but were not served the message.
- Who ran the study. A study commissioned by the publisher is useful evidence but not independent. Ask who ran it, how the control was built, and whether you can see pre-period balance.
Why there is no typical ROI for Epocrates or any POC channel
The search "typical ROI for pharmaceutical brands running programmatic campaigns on Epocrates" comes up a lot. Epocrates is a well-known clinical reference app for clinicians, acquired by athenahealth in 2013. The honest answer is that no responsible person can give you one typical number.
ROI depends on the brand's price and persistence, the specialty, the size of the target list, whether the message is new information or a reminder, competition in the class, the attribution window, and the control design. Two brands on the same placement can see very different results. A case study in one therapeutic area does not transfer to another. If a vendor quotes a typical ROI without those details, ask for the study, the design, and the confidence interval. And see attributed vs. incremental prescriptions before comparing any two figures.
Compliance points for POC measurement
POC ads are prescription drug promotion, so FDA requirements on fair balance and risk information apply, and space in clinical formats is tight. Measurement adds its own checks: links must go to approved destinations, and tracking on any patient-facing page must follow the brand's privacy rules and HHS guidance on online tracking where it applies. This is not legal advice; your MLR and privacy teams make the call.
Practical takeaway
Before your next point-of-care flight, send each partner a one-line request: "For each placement on our plan, list which tags you accept and whether you can deliver an NPI-level engagement file." Their answers tell you exactly which measurement is possible, and they prevent the week-three surprise of a placement that never reported.
Frequently asked questions
Can I put a tracking pixel inside an EHR ad?
Usually not in the way you would on the open web. Many EHR and e-prescribing environments do not allow third-party pixels or restrict them heavily, so engagement is reported by the platform. Ask each partner what tags, if any, they support and in which placements.
What is the typical ROI for pharma brands advertising on Epocrates?
There is no reliable typical figure that applies across brands. Results depend on the brand, specialty, message, competitive situation, and how the study was designed. Ask the publisher for Rx lift studies in your therapeutic area, and ask who ran them and how the control was built.
How do you measure physician engagement at the point of care?
Use the platform's engagement reporting (impressions, opens, clicks, content views) by NPI where available, then connect exposed NPIs to prescription data through a measurement partner to see whether prescribing changed. Engagement is the early signal; Rx lift is the outcome.
Are point-of-care ads regulated differently?
Point-of-care promotion is still prescription drug promotion, so FDA rules on fair balance and required information apply. Formats inside clinical workflow often have tight space limits, which affects how risk information and links are handled. Check with your regulatory team.
Sources
- HHS, Use of Online Tracking Technologies by HIPAA Covered Entities
- FDA, Basics of Drug Ads
- eCFR, 21 CFR Part 202 Prescription Drug Advertising
- Media Rating Council, Standards and Guidelines
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.